arrow
S

Simon Laban

Ulm University Medical Center
H指数:30
被引数:5,964

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial

作者更正:MAGE-A4/MAGE-A8靶向TCR基双特异性T细胞接合剂在复发和/或难治性实体瘤中的应用:一项1期临床试验

2026-06-190
OAAI
MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial

MAGE-A4/MAGE-A8靶向TCR基T细胞连接器在复发和/或难治性实体瘤中的研究:一项1期临床试验

2026-05-310
OAAI
CD3 and PD-L1 tissue expression have synergistic value in head and neck squamous cell carcinoma prognosis

CD3和PD-L1组织表达在头颈鳞状细胞癌预后中具有协同价值

2026-04-160
OAAI
Evaluation of an HPV16-L1 antibody rapid test for oropharyngeal cancer diagnosis: diagnostic accuracy and challenges in real-world settings

HPV16-L1抗体快速检测在口咽癌诊断中的应用评估:诊断准确性与真实世界环境中的挑战

2025-12-110
OAAI
Health-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell carcinoma

健康相关生活质量结局:来自KEYNOTE-412的研究——头颈鳞状细胞癌患者接受含或不含有pembrolizumab的化疗与放疗联合治疗的结果

2025-10-060
OAAI
Co-Stimulatory and Immune Checkpoint Molecule Expression on Peripheral Immune Cells Differs Age Dependently Between Healthy Donors and Patients with Head and Neck Squamous Cell Carcinoma

外周免疫细胞上共刺激分子和免疫检查点分子的表达,在健康供者与头颈鳞状细胞癌患者之间存在年龄依赖性差异。

2025-10-020
OAAI
5-Aza-2′-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD4 T cells☆

5-氮杂-2'-脱氧胞苷 (地西他滨) 增加头颈部鳞状细胞癌中癌-睾丸抗原的表达,并改变免疫检查点的表达,尤其是在CD39-positive CD8和CD4 T细胞中 ☆

2025-01-010
OAAI
Primary results from TACTI-003: A randomized phase IIb trial comparing eftilagimod alpha (soluble LAG-3) plus pembrolizumab versus pembrolizumab alone in first-line recurrent or metastatic head and neck squamous cell carcinoma with CPS ≥1

TACTI-003试验的初步结果:一项随机IIb期临床试验,比较eftilagimod alpha(可溶性LAG-3)联合pembrolizumab与单独使用pembrolizumab治疗CPS ≥1的初治复发或转移性头颈部鳞状细胞癌。

2024-09-010
PRE
Multi-omics analysis of overexpressed tumor-associated proteins: gene expression, immunopeptide presentation, and antibody response in oropharyngeal squamous cell carcinoma, with a focus on cancer-testis antigens
2024-07-291
OAAI
Machine Learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma - knowledge obtained from the CheckRad-CD8 trial
2024-03-012
OAAI